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Abstract
Brain norepinephrine and dopamine regulate a variety of critical behaviors such as stress, learning,
memory, and drug addiction. Here, we demonstrate differences in the regulation of in vivo
neurotransmission for dopamine in the anterior nucleus accumbens (NAc) and norepinephrine in
the ventral bed nucleus of the stria terminalis (vBNST) of the anesthetized rat. Release of the two
catecholamines was measured simultaneously using fast-scan cyclic voltammetry (FSCV) at two
different carbon-fiber microelectrodes, each implanted in the brain region of interest.
Simultaneous dopamine and norepinephrine release was evoked by electrical stimulation of a
region where the ventral noradrenergic bundle (VNB), the pathway of noradrenergic neurons,
courses through the ventral tegmental area/substantia nigra (VTA/SN), the origin of dopaminergic
cell bodies. The release and uptake of norepinephrine in the vBNST were both significantly slower
than for dopamine in the NAc. Pharmacological manipulations in the same animal demonstrated
that the two catecholamines are differently regulated. The combination of a dopamine autoreceptor
antagonist and amphetamine significantly increased basal extracellular dopamine whereas a
norepinephrine autoreceptor antagonist and amphetamine did not change basal norepinephrine
concentration. α-Methyl-p-tyrosine, a tyrosine hydroxylase inhibitor, decreased electrically evoked
dopamine release faster than norepinephrine. The dual-microelectrode FSCV technique along with
anatomical and pharmacological evidence confirms that dopamine in the NAc and norepinephrine
in the vBNST can be monitored selectively and simultaneously in the same animal. The high
temporal and spatial resolution of the technique enabled us to examine differences in the dynamics
of extracellular norepinephrine and dopamine concurrently in two different limbic structures.
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Dopamine and norepinephrine, the major catecholamines in the central nervous system, are
involved in a number of behaviors including learning, memory, arousal, stress, and drug
addiction (Owesson-White et al. 2008, Onaka & Yagi 1998, Aston-Jones & Cohen 2005,
Aston-Jones et al. 1999, Berridge & Waterhouse 2003, Forray & Gysling 2004,
Weinshenker & Schroeder 2007, Aragona et al. 2008, Phillips & Wightman 2003).
Noradrenergic neurons project widely throughout the brain to areas such as the thalamus,
hippocampus, hypothalamus, bed nucleus of the stria terminalis (BNST), and cortex
(Berridge & Waterhouse 2003, Paxinos 1995, Harley 2004). Dopaminergic neurons project
heavily to the frontal cortex, striatum, and limbic areas such as the anterior nucleus
accumbens (NAc) and the amygdala (Harley 2004, Moore & Bloom 1978). However, many
of the rat brain regions that have appreciable amounts of catecholamines are often only a
few hundred microns across. Thus, techniques with high spatial (submillimeter) as well as
temporal (subsecond) resolution are required to evaluate the rapid catecholamine
fluctuations in these discrete locations. The high temporal and spatial resolution achieved
with fast-scan cyclic voltammetry (FSCV) at carbon-fiber microelectrodes has been
successfully used to characterize dopamine dynamics in several brain regions (Stamford &
Justice 1996, Robinson et al. 2008, Garris & Wightman 1995b). Our previous work showed
that FSCV can also measure norepinephrine release, although it needs to be used in
conjunction with select pharmacological agents and careful histological measurements of
electrode placement to distinguish norepinephrine from dopamine (Park et al. 2009, Park et
al. 2010). Norepinephrine was found to be the primary released catecholamine in the vBNST
while dopamine was the predominant catecholamine released in the NAc.
Although the regulatory mechanisms of dopamine and norepinephrine neurotransmission
have many similarities, previous studies have revealed important differences (Mitchell et al.
1994, Garris & Wightman 1995a, Park et al. 2009, Weinshenker & Schroeder 2007). Here,
we used FSCV with two separate carbon-fiber microelectrodes to study regulation of
norepinephrine in the vBNST and dopamine in the NAc simultaneously in the same animal.
Simultaneous measurements in the same animal eliminate experimental confounds such as
variable levels of anesthesia and allow direct comparison of neurotransmitter dynamics
under identical conditions (Zachek et al. 2010). Here, simultaneous release of
norepinephrine in the vBNST and dopamine in the NAc was evoked by electrical stimulation
of the ventral tegmental area and substantia nigra (VTA/SN) region, the site of dopamine
cell bodies. Because the ventral noradrenergic bundle (VNB), the pathway of noradrenergic
neurons which originates mainly from nucleus of the solitary tract (NST, A2) and A1 cell
group, passes directly through this region (Ungerstedt 1971, Miyahara & Oomura 1982,
Saphier 1993), stimulation evokes release of both catecholamines (Park et al. 2009). In the
present study, we demonstrate successfully for the first time simultaneous measurement of
both electrically evoked norepinephrine and dopamine in the two brain regions for the
comparison of their in vivo characteristics and the drug effects on their regulation. We




Adult male Sprague-Dawley rats weighing between 280–400 g were purchased from Charles
Rivers (Wilmington, MA) and housed in temperature and humidity controlled rooms with a
12 h light-dark cycle. Food and water were continuously available ad libitum. All
procedures for handling and caring for the laboratory animals were in accordance with the
Park et al. Page 2













Guide for Care and Use of Laboratory Animals and were approved by the Institutional
Animal Care and Use Committee of the University of North Carolina at Chapel Hill.
Surgery
Rats were anesthetized with urethane (1.5 mg/kg) and placed in a stereotaxic frame (David
Kopf Instruments, Tujunga, CA). All coordinates were obtained from the rat brain atlas
(Paxinos & Watson 2007). Anteroposterior (AP), mediolateral (ML) and dorsoventral (DV)
positions were referenced from bregma. The skull surface was exposed, and four small holes
were drilled in the skull for insertion of electrodes. The instrumentation has been described
in Takmakov et al. (Takmakov et al.). The bipolar, stainless-steel stimulating electrode
(Plastics One, Roanoke, VA) was placed into the VTA/SN (AP −5.2 mm, ML 1.2 mm, DV
from −8.0 to −9.0 mm). The stimulating electrode was insulated to the tip (0.2 mm
diameter) and the tips were separated by ~ 1.0 mm. The Ag/AgCl reference electrode was
placed into the contralateral cortex and was held with dental cement in contact with the skull
to minimize the number of manipulators used. The pia mater was punctured, removed and
two carbon-fiber microelectrodes were implanted vertically into vBNST (AP 0.0 mm, ML
+1.2 mm, DV from −6.5 to −7.5 mm) and NAc (AP +1.7 mm, ML +1.0 mm, DV from −5.5
to −7.5 mm). Temperature was maintained at 37 °C by a heating pad (Harvard Apparatus,
Holliston, MA).
Electrical stimulation
Pulses delivered to the stimulating electrode were computer-generated with a 6711 PCI card
(National Instruments, Austin, TX, USA) and were optically isolated from the
electrochemical system (NL 800A, Neurolog, Digitimer Ltd, Hertfordshire, UK). The
electrical stimulation consists of biphasic square wave pulses (300 μA, 2 ms each phase
unless otherwise noted), and stimulation frequencies between 10 to 60 Hz were applied.
Normally, the number of stimulus pulses was held constant at 60. Each stimulation was
applied every 4 or 5 min to allow time for releasable stores to return to their original levels
(Kita et al. 2007).
Fast-Scan cyclic voltammetry (FSCV)
Glass-encased cylindrical carbon-fiber and Ag/AgCl reference electrodes were prepared as
described earlier (Cahill & Wightman 1995). T-650 carbon fibers (Thornel, Amoco Corp.,
Greenville, SC) with an exposed length of 75 – 100 μm and 6 μm in nominal diameter were
used. The experimental setup for dual measurement has been described previously (Zachek
et al. 2009, Zachek et al. 2010). A locally modified version of TH1- software was used with
a Quad UEI instrument that has four independent current transducers and can support four
different carbon-fiber microelectrodes (University of North Carolina Department of
Chemistry Electronic Shop). Both of the carbon-fiber microelectrodes were referenced to the
sole reference electrode. A triangular waveform (−0.4 to +1.3 V and back to −0.4 V, 400V/
s, repeated at 100 ms intervals) was simultaneously applied to both microelectrodes. The
triangular waveform was low-pass filtered at 2 kHz. Data were digitized and processed
using NI-6711 and NI-6251 DAC/ADC cards and TH-1 software. Background-subtracted
cyclic voltammograms were obtained by digitally subtracting voltammograms collected
during baseline recording from those collected during electrical stimulation event. Temporal
responses were determined by monitoring the current at the peak potential for catecholamine
oxidation in successive voltammograms (pH changes (Takmakov et al. 2010) caused
minimal interference in the present studies). Because the carbon-fiber microelectrode was
used to generate a lesion for histology, the oxidation current was converted to concentration
based on the averaged dopamine or norepinephrine calibration factors 6.9 ± 0.3 pA/
(μM·μm2) for dopamine, 4.5 ± 0.2 pA/(μM·μm2) for norepinephrine (Park et al. 2010). A
lesion was made at the recording site by applying constant current (20 μA for 10 s) to the
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implanted carbon-fiber electrodes as described earlier (example in Supplementary Fig. 1)
(Park et al. 2009, Park et al. 2010). Brains were removed from the skull and stored in 10 %
formaldehyde for at least 3 days, and coronally sectioned into 40–50 μm thick slices with a
cryostat. The sections mounted on slides were stained with 0.2 % thionin, and coverslipped
before viewing under a light microscope.
Drugs and reagents
All chemicals and drugs were reagent-quality and were used without additional purification.
Drugs were obtained from Sigma-Aldrich (St. Louis, MO, USA). In vitro postcalibration of
carbon-fiber microelectrodes was performed in a Tris buffer solution at pH 7.4 containing
15 mM Tris, 140 mM NaCl, 3.25 mM KCl, 1.2 mM CaCl2, 1.25 mM NaH2PO4, 1.2 mM
MgCl2, and 2.0 mM Na2SO4 in double distilled water (Mega Pure System, Corning
Glasswork, Corning, NY). The following drugs, desipramine-HCl, raclopride-HCl,
yohimbine-HCl, idazoxan-HCl, d-amphetamine sulfate, α-methyl-DL-p-tyrosine methyl
ester-HCl and L-3,4-dihydroxyphenylalanine methyl ester-HCl were dissolved in saline.
GBR 12909-HCl was dissolved in double distilled water and then diluted with saline. All
drugs were injected intraperitoneally (i.p.).
Data analysis
Voltammetric data are presented in a form of color plots where abscissa represents time,
ordinate represents potential and current is encoded in false color (Michael et al. 1999).
Clampfit 8.1 as part of pCLAMP 8.1 software package (Axon Instruments, Foster City, CA)
was used to analyze all data as described earlier (Park et al. 2006). tr is the time to reach the
maximum concentration and t1/2, was taken as the time to descend from its maximum value
to half of that value. [CA]max is the maximal evoked catecholamine concentration.
Catecholamine transients were identified by a principal component regression algorithm as
descried earlier (Heien et al. 2004, Keithley et al. 2009). Catecholamine transients were
defined as signals that were greater than five times the root-mean-square noise level and
were analyzed for frequency, amplitude, and t1/2 using Mini Analysis Software
(Synaptosoft, Decatur, GA, USA) (Park et al. 2010). Data are represented as mean ± S.E.M.
and ‘n’ values indicate the number of rats. Mean values were compared by using the
Student’s t test (GraphPad Software, San Diego, CA, USA) and P < 0.05 was regarded as
statistically significant.
Results
Simultaneous monitoring of dopamine in the NAc and norepinephrine in the vBNST
Electrical stimulation (60 Hz) of the VTA/SN causes simultaneous catecholamine release
that can be monitored in the NAc and vBNST in a single animal (Fig. 1). Both the color
plots and the individual background subtracted voltammograms establish the signals are due
to catecholamines. Both catecholamines are oxidized at ~ +0.65 V (dashed line) and their
catecholamine-o-quinone forms are reduced at ~ −0.23 V (solid line). The current at ~ +0.65
V in both regions increased rapidly during electrical stimulation and afterwards decreased
back to the prestimulation basal level (Fig. 1c and d). This time-dependent concentration
during the stimulation increase is due to the altered balance between release and uptake of
catecholamines and diffusion from multiple varicosities near the microelectrodes. After the
stimulation catecholamine concentrations decrease due to uptake coupled to diffusion
(Garris & Wightman 1995b). Our prior pharmacological and histological characterization of
these regions established that dopamine is the predominant catecholamine released in the
NAc and norepinephrine is the predominant catecholamine in the vBNST (Park et al. 2009,
Park et al. 2010). The average maximum dopamine concentration evoked in the NAc was ~
4 fold higher than the maximal norepinephrine concentration in the vBNST evoked by the
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same stimulation (Table 1). The rise time (tr), the time from the signal onset to the point the
maximum is reached of the dopamine concentration and its half-decay time (t1/2), the time to
descend from its maximum value to half of that value, were significantly faster than those of
norepinephrine in the vBNST (P < 0.05 for both tr and t1/2) (Table 1).
Effects of the stimulation conditions on dopamine release in the NAc and norepinephrine
release in the vBNST
Subsecond changes of dopamine and norepinephrine concentration simultaneously elicited
by various electrical stimulation parameters (stimulation frequency, pulse number and pulse
width) were investigated and compared (Fig. 2). Increasing the stimulation frequency from
10 to 60 Hz (60 pulses with 2 ms pulse width) caused an increase in both evoked dopamine
in the NAc and norepinephrine in the vBNST (representative examples in Fig. 2a). While the
evoked dopamine concentration in the NAc during low frequency stimulations (≤20 Hz)
reached a plateau, the norepinephrine concentration in the vBNST continued to increase
during the stimulation. At higher frequencies (> 20 Hz), dopamine and norepinephrine
concentrations increased continuously during the stimulation. The maximal responses
observed in all animals are shown in Figure 2d.
Both evoked dopamine and norepinephrine concentrations increased with pulse numbers
from 10 to 120 pulses (at 60 Hz with 2 ms pulse width, representative examples in Fig. 2b,
average responses in Fig. 2e). Measurable responses (signal to noise (S/N) ≥ 5) in this study
were normally observed with greater than 10 pulses for norepinephrine and greater than 5
pulses for dopamine at 60 Hz. The effect of stimulus pulse width was also evaluated.
Evoked norepinephrine concentrations in the vBNST were less sensitive to pulse width than
was evoked dopamine in the NAc (representative example in Fig. 2c, average responses in
Fig. 2f).
Spatial distribution of VTA/SN sites for evoked catecholamine release
The VNB, the pathway of noradrenergic neurons, passes within the VTA/SN. We examined
the distribution of sites of the VNB that project to the vBNST and of the VTA/SN that
project to the NAc by mapping the maximal stimulated release at different depths of the tips
of the bipolar stimulating electrode. The carbon-fiber microelectrodes were fixed at
locations in the NAc and the vBNST that supported robust catecholamine release. The
stimulating electrode was lowered through the VTA/SN region in ~ 100 to 200μm
increments from 6.7 to 9.2 mm below the skull surface as electrically evoked (60 Hz, 60
pulses) release was recorded in the two terminal regions. Figure 3a (left) shows the coronal
plane (AP −5.2 mm) and track (dotted lines, centered on 1.2 mm ML) of the tips (spaced ~
1.0 mm apart) of the bipolar stimulating electrode for this experiment (Park et al. 2009).
When averaged from multiple animals, evoked release of dopamine in the NAc was
immeasurable with the stimulating electrode above 7.0 mm or below 9.2 mm. The maximal
evoked dopamine concentration was observed when the stimulating electrode was ~ 8.3 mm
from the skull surface (solid line, Fig. 3a, right). In the individual example shown in Figure
3b, dopamine in the NAc was not observed until the stimulating electrode was below a depth
of ~ 7.5 mm. The maximal concentration evoked concentration was observed when the
stimulating electrode was at ~ 8.3 mm and then it decreased dramatically when the
stimulating electrode was lowered to 9.2 mm. In contrast, the average evoked
norepinephrine concentration in the vBNST showed less dependence on the depth of the
stimulating electrode (dotted line, Fig. 3a right). The individual traces for evoked
norepinephrine in the vBNST show release with the stimulating electrode above 7.3 mm
(Fig. 3b). When the stimulating electrode was lowered to 9.2 mm, norepinephrine release
only decreased 20 % from the maximal response that was observed at 8.3 mm. In general,
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maximum dopamine and norepinephrine concentrations were evoked when the stimulating
electrodes was at a depth of ~ 8.3 mm.
Selective dopamine and norepinephrine drug effects on dopamine in the NAc and
norepinephrine in the vBNST
Dopamine and norepinephrine cannot be distinguished based on their voltammograms
though the cyclic voltammograms for the catecholamines are distinct from those for all other
substances establishing a unique identifier for catecholamines (Heien et al. 2003, Park et al.
2009). Although pharmacological evidence previously confirmed that the main
catecholamines released in the vBNST and NAc were norepinephrine and dopamine,
respectively (Park et al. 2009, Park et al. 2010), here we examined the effects of selective
dopamine or norepinephrine drugs simultaneously in the different brain regions of the same
animal. Presynaptic D2 and α2-adrenergic receptors are activated by dopamine and
norepinephrine, respectively, which regulate their release while the norepinephrine
transporter (NET) and dopamine transporter (DAT) regulate their clearance. We studied
simultaneously the influence of the α2-adrenergic receptor antagonist, yohimbine, and D2
receptor antagonist, raclopride, on both electrically evoked norepinephrine and dopamine
release. In addition, the effects of the NET inhibitor, desipramine, and DAT inhibitor, GBR
12909, on the evoked catecholamine responses were simultaneously investigated in both
brain regions.
Twenty minutes after administration of raclopride (2 mg/kg, i.p.), electrically evoked
dopamine concentration ([DA]) and the t1/2 value for dopamine disappearance both
increased in the NAc. Subsequent administration of GBR 12909 (15 mg/kg, i.p.) further
increased [DA] and t1/2 (Fig. 4a). Table 2 presents a summary of the average catecholamine
responses evoked at 60 Hz both before (control) and 20 min after drug administration. In the
presence of raclopride and GBR 12909, only the [DA] and the t1/2 valuein the NAc
significantly increased. In contrast, the dopamine drugs had little effect on evoked
norepinephrine concentration ([NE]) and the t1/2 value in the vBNST within the same animal
(Fig. 4b, Table 2). The norepinephrine drugs, yohimbine (5 mg/kg, i.p.) and desipramine (15
mg/kg, i.p.), were ineffective in altering dopamine overflow in the NAc (Fig. 4c, Table 2).
In contrast, yohimbine increased electrically evoked [NE] and the t1/2 value in the vBNST
and subsequent administration of desipramine (15 mg/kg) following yohimbine, further
increased both [NE] and t1/2 (Fig. 4d, Table 2).
Spontaneous dopamine transients in the NAc were observed after the two dopamine drugs
(Fig. 5). These transients were not observed after the two norepinephrine drugs, and neither
were transients observed under any conditions in the vBNST. The average concentration
amplitude of the dopamine transients in the NAc was 0.18 ± 0.04 μM following GBR 12909
and raclopride, and these occurred with a frequency of ~ 0.41 Hz and t1/2 (0.86 ± 0.06 s, n =
3 rats).
Effects of amphetamine and autoreceptor antagonists on stimulated release of dopamine
in the NAc and norepinephrine in the vBNST
Amphetamine releases newly synthesized catecholamines from a readily releasable pool and
blocks their uptake (Sulzer et al. 2005), but the effects seem to be different at
norepinephrine and dopamine terminals (Sanghera et al. 1979). In the present study,
amphetamine (3.0 mg/kg) caused electrically evoked dopamine and norepinephrine
concentration to increase ([DA] = 147 ± 6.0 % of predrug, P < 0.001 and [NE]=163 ± 7.8 %
of predrug, P < 0.001, n = 5 animals) and it also increased half decay times (t1/2, AMP = 215
± 18 % for dopamine, P < 0.001 and t1/2, AMP = 220 ± 16 % for norepinephrine, P < 0.0001,
n = 5) (Fig. 6a and b). Subsequent administration of raclopride (2.0 mg/kg) following
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amphetamine suppressed electrically evoked dopamine significantly ([DA] AMP+RA = 94.5 ±
11.5 % of predrug, P < 0.01, n = 4) but did not alter evoked norepinephrine from its post-
amphetamine level ([NE] AMP+RA =153.8 ± 7.3, P > 0.05, n = 4 animals)(Fig. 6b, left). The
suppressed dopamine release following amphetamine and raclopride was accompanied by a
dramatic increase in the extracellular basal dopamine concentration (to 2.52 ± 0.76 μM, n =
5) that occurred within 4 min after administration of raclopride (Fig. 6c, left). The
combination of amphetamine and raclopride did not alter the basal norepinephrine level
significantly (Fig. 6c, right). Normally measurement of basal concentrations with FSCV is
complicated by electrode drift (Hermans et al. 2008), but, with these conditions, the cyclic
voltammograms clearly revealed the large increase in basal dopamine concentration (Fig. 6c
inset).
In contrast, idazoxan administration following amphetamine changed neither basal
dopamine levels in the NAc (Fig. 6d, left) nor basal norepinephrine levels in the vBNST
(Fig. 6d, right). The administration of idazoxan (3.0 mg/kg), an α2-adrenergic receptor
inhibitor, following amphetamine further increased electrically evoked norepinephrine
concentration ([NE]AMP+IDA = 208 ± 18 % of predrug value, P < 0.05, n = 4) while it was
ineffective in altering dopamine overflow in the NAc ([DA]AMP+IDA = 134 ± 4.7 %, P >
0.05, n = 4)(Fig. 6a and b, right). Idazoxan was used in this study because its effects are
manifested more rapidly than those of yohimbine. The time to reach maximum effect of
yohimbine is ~ 5 to 10 min longer than idazoxan while the effects of yohimbine on
dopamine and norepinephrine are not significantly different from those of idazoxan.
Effects of synthesis inhibition on stimulated dopamine and norepinephrine release
α-Methyl-p-tyrosine (α-MT), a tyrosine hydroxylase inhibitor, has been used to estimate the
turnover of catecholamines (Kizer et al. 1975). Here, we monitored the release of both
catecholamines evoked by electrical stimulations (60 Hz, 60 pulses) repeated at 5 min
intervals. Evoked catecholamine release following a saline injection (0.5 mL) was stable
over a 2-h period. However, ~ 15 min after α-MT (200 mg/kg) administration, the
electrically evoked dopamine and norepinephrine release began to decrease (Fig. 7a).
Norepinephrine release in the vBNST approached a new base line ~ 60 min after α-MT
administration, where the amplitude was 56.6 ± 3.6 % of the predrug value. Electrically
evoked dopamine decreased continuously and reached a level that was 38.2 ± 5.3 % of the
predrug release at 95 min after administration. Statistical analysis revealed that the two
groups were significantly different 60 min after α-MT administration (P < 0.001) (Fig. 7a).
Both dopamine and norepinephrine release attenuated by α-MT was rapidly restored
following administration of L-DOPA (250 mg/kg), the biochemical precursor of dopamine
(Fig. 7a). Individual representative dopamine and norepinephrine traces recorded in the NAc
and vBNST, simultaneously, before and after the drugs in a same rat are shown in Figure 7b
and c, respectively.
Discussion
In vivo voltammetry has been demonstrated to be a useful tool to monitor the dynamics of
extracellular neurotransmitters. The use of multiple electrodes allows several experiments
that are not possible with single probes. For example, electrodes in arrays have been used to
minimize chemical and electrical interference for enzyme-based electrodes (Parikh et al.
2004, Burmeister et al. 2002, Garguilo & Michael 1996). Electrode arrays have been used to
monitor stimulated dopamine release within the striatum (Lu et al. 1998, Zachek et al. 2010)
and to compare stimulated release in the caudate nucleus and basal lateral amygdala (Garris
& Wightman 1994). Here, we show that in vivo dual-microelectrodes can be used with
FSCV to monitor evoked release of dopamine and norepinephrine simultaneously. The
simultaneous measurements minimize the number of animals required for comparison of the
Park et al. Page 7













two different neurotransmitters while allowing direct comparison of their dynamic processes
and drug effects on them in the same preparation. Here we show that the dynamics of
norepinephrine in the vBNST are slower than for dopamine in the NAc. Furthermore, the
two neurotransmitter systems respond quite differently to pharmacological agents that are
known to act on these systems.
We have taken advantage of the fact that noradrenergic fibers traverse through the VTA/SN
region. Thus, stimulation of this region promotes simultaneous release in the terminal
regions of both catecholamines (Park et al. 2009). Movement of the stimulating electrode
reveals that the region of excitation of noradrenergic fibers is broader than for dopaminergic
processes (Fig. 3). Dopamine content in the NAc is similar to that of norepinephrine in the
vBNST (Park et al. 2009, Park et al. 2010, Kilts & Anderson 1986). However, with the
conditions employed here, it appears that the broad spatial distribution of norepinephrine
fibers limits electrically evoked release in the vBNST to approximately one quarter of that
for dopamine release evoked in the NAc even when the stimulating electrode is placed in a
site that evokes maximal release (Table 1). An alternate interpretation, previously described
in a review, is that the tissue-content normalized release rate of norepinephrine is half that of
dopamine (Garris & Wightman 1995b).
Both dopamine and norepinephrine fibers are unmyelinated, have processes with diameters
of less than 0.5 μm, and have slow conduction velocities of ~0.5 m/s (Aston-Jones et al.
1980, Connor 1975, Grace & Bunney 1983, Phelix et al. 1992). Despite these similarities,
the dynamics of the evoked release profiles of the two catecholamines are quite different.
The rise time for dopamine release is faster than for norepinephrine (Fig. 1 and Table 1).
While the origin of these differences is not understood, it is not due to the difference in
stimulation sites in the present experiments (fibers of passage for norepinephrine, cell body
region for dopamine) because stimulation of dopamine fibers in the medial forebrain bundle
also results in rapid release (Garris & Wightman 1994). Furthermore, norepinephrine release
is less dependent on pulse width than dopamine, with short pulse widths (duration ≤1.0 ms)
being more effective for the activation of noradrenergic release (Fig. 2). Dopamine release
with medial forebrain bundle stimulation also diminishes with short stimulation pulses
(Millar et al. 1985). While the dependence of release on pulse width can be profound (Albert
et al. 2009, Ranck 1975), in this case the difference observed may be due to the different
mechanisms responsible for release at catecholamine terminals. Indeed, release from
dopaminergic terminals has been shown to be more sensitive to the availability of Ca2+ both
in synaptosomes (Okada et al. 1990) and in vivo (Mitchell & Adams 1993). However, the
difference cannot be explained solely in the catecholamine terminal fields. It may be also
due to different biophysical properties of the catecholaminergic fibers.
The slow disappearance of evoked norepinephrine in the vBNST, as measured by t1/2,
indicates that the rate of norepinephrine uptake is approximately half that for dopamine
uptake in the NAc. Consistent with this, norepinephrine uptake in the vBNST was reported
to be significantly slower than dopamine uptake in the striatum and even compared to
norepinephrine uptake in other brain regions (Dugast et al. 2002, Dugast et al. 1994, Capella
et al. 1993, Park et al. 2009). Slow uptake has several consequences. First, slower uptake
allows released norepinephrine in the vBNST to diffuse further from its release sites than
dopamine in the NAc, and allows norepinephrine to participate to a greater degree in
“volume transmission” (Cragg & Rice 2004). Second, because extracellular catecholamines
during a stimulus train are the balance between uptake and release (Wightman et al. 1988),
slow uptake allows protracted increases in norepinephrine concentrations during low
frequency stimuli as illustrated in the 20 Hz stimulations in Figure 2a. Extracellular
dopamine reaches a new steady-state level during the stimulation while norepinephrine
shows a continuous increase. At higher frequencies, there is less time between impulses in a
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train for uptake to operate, so both dopamine and norepinephrine concentrations increase
during the stimulation.
The cyclic voltammograms for dopamine and norepinephrine are virtually identical (Heien
et al. 2004, Park et al. 2009), but they are distinct from metabolites and other interferences
in the extracellular fluid (Baur et al. 1988, Heien et al. 2003). Thus, along with the
voltammetric, anatomical, and neurochemical evidence, the use of select pharmacological
agents is necessary to distinguish the two catecholamines. The simultaneous measurements
shown here clearly confirm the selectivity of the drugs employed. The dopamine drugs
(raclopride, GBR 12909) did not affect electrically evoked norepinephrine release in the
vBNST (Fig. 4). Likewise, the selective norepinephrine drugs (yohimbine, idazoxan,
desipramine) did not affect dopamine release or its spontaneous release in the NAc (Fig. 4).
The results are consistent with our previous studies (Park et al. 2009, Park et al. 2010) and
support the concept that dopamine in the NAc and norepinephrine in the vBNST can be
selectively monitored simultaneously within the same animal using dual-microelectrode
FSCV.
A major difference of the two catecholamine systems is that norepinephrine transients in the
vBNST did not occur following the norepinephrine drugs but, following dopamine drugs,
robust dopamine transients were observed in the NAc (Fig. 5). This difference may be
explained by the different types of phasic (burst) firing that have been documented for
dopaminergic and noradrenergic neurons. Dopaminergic neurons display tonic and phasic
modes of firing that occur over longer time periods than for noradrenergic neurons that
display only brief phasic discharge events (Berridge & Waterhouse 2003). If phasic
noradrenergic excitatory responses in anesthetized animals occur with a shorter duration (<
100 ms) and lower frequency ( 10 Hz) than the phasic dopaminergic responses, the small
concentration changes of norepinephrine transmission may not be observed. Alternatively,
the firing rate of noradrenergic neurons may be affected with anesthesia more than that of
dopaminergic neurons. Anesthesia or sleep causes a dramatic depression in firing of
noradrenergic cells (< 1 Hz) in the locus coeruleus (Foote et al. 1980, Berridge &
Waterhouse 2003). In contrast, the average firing rate of dopaminergic neurons does not
significantly vary between awakened and deeply anesthetized rats, although there is a
reduction of their burst firing (Fa et al. 2003).
The dual microelectrode approach is particularly useful to contrast the actions of drugs that
are nonselective. For example, amphetamine can inhibit NET and DAT and also causes
reverse transport of catecholamines due to its inhibition of the vesicular monoamine
transporter (Sulzer et al. 2005). Here, amphetamine increased the half-life of both
extracellular catecholamines after stimulation and elevated the maximal concentration,
consistent with its actions as a transport inhibitor (Fig. 6)(Ramsson et al. 2011). However,
when amphetamine was followed by the selective D2 antagonist, raclopride, release of
dopamine returned to pre-amphetamine levels whereas evoked norepinephrine release was
unaffected (Fig. 6). Inspection of the baseline level in amphetamine treated animals after
administration of the autoreceptor antagonists provides evidence of a massive spontaneous
dopamine efflux following raclopride, a phenomenon not seen under most other conditions.
The basal level of catecholamines following amphetamine alone does not change
sufficiently to be detected by in vivo voltammetry (Ramsson et al. 2011, Wiedemann et al.
1991), although microdialysis studies have reported basal level increases in catecholamine
concentrations following amphetamine (Kuczenski et al. 1997, L’Heureux et al. 1986).
Raclopride can reverse the decrease in firing rates of dopaminergic neurons caused by
amphetamine (Shi et al. 2007, Shi et al. 2000), and this should lead to this spontaneous
release. Similar spontaneous release has been observed following the combination of the
dopamine uptake inhibitors such as nomifensine, GBR 12909, and cocaine with D2
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antagonists (Venton & Wightman 2007, Park et al. 2010). However, only amphetamine
coupled with a D2 antagonist decreased subsequent stimulated dopamine release. For
example, release following GBR 12909 and raclopride increased evoked dopamine
concentration (Fig. 4). We attribute the decreased stimulated release following amphetamine
and a D2 antagonist to a dual-mechanism: the displacement of vesicular dopamine by
amphetamine and the depletion of releasable stores caused by release following increased
neuronal firing after raclopride administration.
Following amphetamine, evoked norepinephrine release was further increased by the
subsequent administration of the α2-adrenoceptorinhibitor, idazoxan, whereas dopamine
release was unaffected. The different effects on noradrenergic neurons of the combination of
amphetamine and an autoreceptor blocker are consistent with the idea that releasable stores
of norepinephrine are more able to exchange with reserve stores (Sanghera et al. 1979). The
lack of spontaneous release on noradrenergic neurons occurs despite the fact that
amphetamine causes activation of the terminal norepinephrine autoreceptor (Nakamura et al.
1982), a process reversed by a norepinephrine autoreceptor antagonist (Curet et al. 1992). It
has been previously noted that the degree of amphetamine’s actions on dopaminergic and
noradrenergic neurotransmission are different (Ryan et al. 1985). This may be due to the
potency of amphetamine for inducing release is greater for dopaminergic than noradrenergic
neurons (Raiteri et al. 1974, Ryan et al. 1985), although the opposite conclusion was
reached for release in isolated brain slices (Rothman & Baumann 2003).
α-MT, a central tyrosine hydroxylase inhibitor, decreased both dopamine release in the NAc
and norepinephrine release in the vBNST, which is in accordance with earlier studies with in
vivo microdialysis (Shimizu et al. 1990) and FSCV (Millar et al. 1985) although the degree
of inhibition of brain catecholamine synthesis is dependent on dose and stimulating pulse
numbers. α-MT levels in the brain reach a maximum 1–2 h after i.p. injection (Widerlov &
Lewander 1978). Our result shows that norepinephrine is depleted less than dopamine by α-
MT administration. Consistent with this, the duration of synthesis inhibition and storage
depletion after α-MT administration was shorter lasting for norepinephrine than for
dopamine from endogenous catecholamine measurements by biochemical methods
(Widerlov & Lewander 1978). In addition, the 50% effective dose (ED50) for synthesis
inhibition of dopamine was half of the ED50 for that of norepinephrine (Widerlov &
Lewander 1978). The faster depletion of dopamine than norepinephrine is again consistent
with a marked difference between dopamine and norepinephrine containing neurons in the
functional relationship between their releasable and storage pools (Sanghera et al. 1979). In
dopamine neurons, the rate of transfer between stored and readily-releasable amine pools is
quite slow. In contrast, in norepinephrine neurons, there appears to be a more rapid
mobilization of the stored amine to readily releasable sites.
It is interesting that two neuronal systems, which superficially seem anatomically and
biochemically similar, are so significantly different in their storage and control mechanisms
for regulating release and clearance (McMillen et al. 1980, Mitchell & Adams 1993). The
results of this study suggest that neural regulation of dopamine and norepinephrine in the
brain differ and the ability to simultaneously study dopamine and norepinephrine
neurotransmission in different brain regions will facilitate research on the distinct roles and
functions of these catecholamines in animal behaviors and disease states for future study.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Signal identification of voltammetric data recorded in the NAc and vBNST
Upper panels: color plots for the voltammetric data, with current changes encoded in false
color for dopamine in NAc (a) and norepinephrine in the vBNST (b). The sets composed of
all background-subtracted cyclic voltammograms recorded for 40 s before and after
electrical stimulation of the VTA/SN and VNB (60 Hz, 60 pulses; delivered at 0 s).
Catecholamine concentration changes are apparent in the color plots at the potential for their
oxidation (~ 0.65 V, dotted line) and reduction (~−0.23 V, solid line). The traces of
dopamine in the NAc (c) and norepinephrine in the vBNST (d) evoked by the electrical
stimulation measured. The traces (dotted line) were shown at the potential at which
catecholamine is oxidized. Electrical stimulation is indicated with the solid red bars under
the traces. Insets: background-subtracted cyclic voltammograms recorded at the maximum
of the evoked release.
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Figure 2. Comparison of dopamine response in the NAc to norepinephrine response in the
vBNST
Individual dopamine (dotted line) trace in the NAc and norepinephrine (solid line) trace in
the vBNST as a function of stimulation frequency (10, 20, 40, and 60 Hz) at 60 pulses (a),
pulse number (10, 40, 80, and 120) at 60 Hz (b) and pulse width (0.2, 0.5, 1.0, and 2.0 ms)
(c) are shown. Electrical stimulation is indicated with the solid red bars under the traces.
Maximal catecholamine responses in the NAc and the vBNST as a function of stimulation
frequency (d), pulse number (e) and pulse width (f). Relative responses in (d), (e) and (f) are
the monitored response ([CA]x) divided by the maximum response ([CA]max). *indicates
significantly different from the evoked dopamine in the NAc (P < 0.05).
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Figure 3. Maps of electrically evoked catecholamine responses measured in the NAc and vBNST
as a function of depth of the stimulating electrode
Coronal section (AP −5.2 mm from bregma) illustrates the approximate path of the
stimulating electrode tips (dotted lines) aimed at the VNB (filled region SN (striped) and
VTA (dotted)) (a, left). Relative intensity of dopamine in NAc (—with triangles) and
norepinephrine in vBNST (··· with squares) evoked at different positions of the stimulating
electrode (60 Hz, 60 pulses) (a, right). The coronal sections were taken from the atlas of
Paxinos and Watson (2007). Approximate placements of the VTA/SN and VNB in the
diagram were based on the previous studies (Ungerstedt 1971, Paxinos & Watson 2007,
Park et al. 2009). Representative concentration versus time traces for dopamine (b, left) and
norepinephrine (b, right) release at different positions of the stimulating microelectrode in
the same animal. Distance (mm) on the left is depth from the skull for stimulating electrode.
Electrical stimulation is indicated with the solid red bars under the traces. Abbreviations
used: VTA, ventral tegmental area; SN, substantia nigra; VNB, ventral tegmental area.
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Selective dopamine and norepinephrine drug effect on the release and uptake of
catecholamines in the NAc and vBNST. Raclopride (RA, ···, 2 mg/kg) increased both [DA]
and t1/2 in the NAc and administration of GBR 12909 (GBR, ---, 15 mg/kg) after RA further
increased both [DA] and t1/2 in the NAc (a) but these dopamine drugs have no effect on
[NE] and t1/2 in vBNST (b). Yohimbine (YO, ···, 5 mg/kg) and yohimbine with desipramine
(DMI, ---, 15 mg/kg) have no effect on [DA] and t1/2 in the NAc (c) but increased [NE] and
t1/2 of the signal in the vBNST (d). Electrical stimulation is indicated with the solid red bars
under the traces.
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Dopamine drugs induced dopamine concentration transients in the NAc. Two-dimensional
color plot representation of the background-subtracted cyclic voltammograms collected over
30 sec (a, c) before and (b, d) following administration of the dopamine drugs (raclopride (2
mg/kg, i.p.) and GBR 12909 (15 mg/kg, i.p.)) in the NAc and the vBNST. Dopamine
concentration changes are apparent in the color plot (b) at the potential for its oxidation (~
0.65 V) and its reduction (−0.2 V). Principal component regression was used to extract the
time course of the catecholamine concentration transients (lower traces in a-d). Times are
indicated by the vertical bars. Inset: The cyclic voltammogram recorded at the time
indicated by the arrow (b) was identical to that for dopamine.
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Amphetamine, D2 and α2-adrenergic receptor inhibitor effect on the release and uptake of
catecholamines in the NAc and vBNST. Amphetamine (AMP, ···, 3 mg/kg) increased both
[CA] and t1/2 (a and b) but administration of raclopride (RA, ---, 2 mg/kg) following AMP
decreased electrically evoked [DA] in the NAc (a, left). The combined drug (AMP + RA)
has no effect on [NE] in vBNST (b, left) but idazoxan (IDA, ---, 3 mg/kg) following AMP
further increased [NE] in the vBNST (b, right). The combined drug (AMP + IDA) has no
effect on [DA] in the NAc (a, right). The combined drug (AMP + RA) increased basal
dopamine concentration but not basal norepinephrine concentration (c). The combined drug
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(AMP + IDA) has no effect on both basal catecholamine concentrations (d). Electrical
stimulation is indicated with the solid red bars under the traces.
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Effects of α-methyl-p-tyrosine (α-MT) and L-DOPA on the release of dopamine in the NAc
and norepinephrine in the vBNST. (a) The time course of the change in evoked dopamine
concentration in the NAc and norepinephrine in the vBNST and (b) dopamine and (c)
norepinephrine concentration changes in a same animal after intraperitoneal injection of α-
MT and L-DOPA. Each datum point is shown as mean ± S.E.M. α-MT decreased both
electrically evoked dopamine and norepinephrine release and L-DOPA restored both
attenuated dopamine and norepinephrine release. Electrical stimulation is indicated with the
solid red bars under the traces.
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Table 1
Numerical parameters measured from the dopamine in the NAc and norepinephrine in the vBNST evoked by
the electrical stimulation (60 Hz, 60 pulses).
Rats (n=6) Dopamine in the NAc Norepinephrine in the vBNST
[CA]max (μM) 1.35 ± 0.33 0.31 ± 0.05*
tr (s) 1.04 ± 0.14 1.70 ± 0.17*
t1/2 (s) 1.19 ± 0.38 2.59 ± 0.47*
[CA]max is the maximal evoked catecholamine concentration; tr is the time to reach to [CA]max from the start of the stimulation; t1/2 is the time
required for catecholamine overflow to decay to 50 % of the maximum. Values represent the mean ± S.E.M. The values were compared by
unpaired t-tests.
*
(P < 0.05) indicates significantly different from the evoked dopamine in the NAc.
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Table 2
Effects of yohimbine (YO, 5 mg/kg), YO + desipramine (DMI, 15 mg/kg), raclopride (RA, 2 mg/kg) and RA
+ GBR 12909 (GBR,15 mg/kg) on evoked catecholamine release.
Drug (n = 4) (%) of control
Region NAc vBNST
YO
[CA] 102 ± 3 153 ± 7*
t1/2 105 ± 10 171 ± 18*
Yo + DMI
[CA] 94.0 ± 3.8 203 ± 15*#
t1/2 107 ± 9.5 368 ± 49*#
RA
[CA] 169 ± 6* 102 ± 3
t1/2 200 ± 21* 89.8 ± 6.0
RA + GBR
[CA] 299 ± 38*# 95.1 ± 3.5
t1/2 305 ± 48*# 96.9 ± 5.0
Data are mean ± S.E.M. and were obtained during 60 Hz stimulations (60 pulses). The evoked catecholamine concentration, [CA], and the time
required for catecholamine overflow decay to 50 % of the maximum, t1/2, are shown.
*
Indicates significantly different from control values (P < 0.05).
#
Significantly different versus a single drug (yohimbine or raclopride) (P < 0.05). Values represent the mean ± S.E.M.
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